Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Screen on your Watchlists and Portfolios with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Cytek Biosciences Inc (CTKB)

Cytek Biosciences Inc (CTKB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 638,046
  • Shares Outstanding, K 127,865
  • Annual Sales, $ 200,450 K
  • Annual Income, $ -6,020 K
  • EBIT $ -32 M
  • EBITDA $ -21 M
  • 60-Month Beta 1.29
  • Price/Sales 3.32
  • Price/Cash Flow 149.85
  • Price/Book 1.75

Options Overview Details

View History
  • Implied Volatility 80.92% (-8.63%)
  • Historical Volatility 85.96%
  • IV Percentile 6%
  • IV Rank 5.19%
  • IV High 883.63% on 10/03/25
  • IV Low 37.01% on 09/05/25
  • Expected Move (DTE 12) 1.11 (22.14%)
  • Put/Call Vol Ratio 0.04
  • Today's Volume 27
  • Volume Avg (30-Day) 163
  • Put/Call OI Ratio 0.10
  • Today's Open Interest 1,947
  • Open Int (30-Day) 1,313
  • Expected Range 3.89 to 6.10

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 6 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/25
See More
  • Average Estimate -0.03
  • Number of Estimates 2
  • High Estimate -0.02
  • Low Estimate -0.04
  • Prior Year 0.07
  • Growth Rate Est. (year over year) -142.86%

Price Performance

See More
Period Period Low Period High Performance
1-Month
4.26 +17.14%
on 11/06/25
6.18 -19.26%
on 11/17/25
+0.98 (+24.44%)
since 11/05/25
3-Month
3.28 +52.13%
on 09/25/25
6.18 -19.26%
on 11/17/25
+0.97 (+24.13%)
since 09/05/25
52-Week
2.37 +110.55%
on 05/23/25
7.30 -31.64%
on 01/14/25
-1.55 (-23.70%)
since 12/05/24

Most Recent Stories

More News
TIME Recognizes Cytek® Biosciences as One of America’s Growth Leaders of 2026

FREMONT, Calif., Nov. 12, 2025 (GLOBE NEWSWIRE) -- Spectral flow cytometry leader  Cytek Biosciences, Inc. (Nasdaq: CTKB) today announced its inclusion on TIME’s 2026 list of America’s Growth Leaders....

CTKB : 4.99 (-4.04%)
Cytek® Muse® Micro Cell Analyzer Wins BioTech Breakthrough Award for Drug Discovery Solution of the Year

FREMONT, Calif., Nov. 06, 2025 (GLOBE NEWSWIRE) -- Cytek Biosciences, Inc. (Nasdaq: CTKB) announced today that its Cytek ® Muse ® Micro cell analyzer has been named Drug Discovery Solution...

CTKB : 4.99 (-4.04%)
Cytek Biosciences to Participate in Upcoming Investor Conferences

FREMONT, Calif., Nov. 06, 2025 (GLOBE NEWSWIRE) -- Cytek Biosciences, Inc. (Nasdaq: CTKB), a leading cell analysis solutions company, today announced the company will be participating in the following...

CTKB : 4.99 (-4.04%)
Cytek Biosciences Reports Third Quarter 2025 Financial Results

FREMONT, Calif., Nov. 05, 2025 (GLOBE NEWSWIRE) -- Cytek ®  Biosciences, Inc. (“Cytek Biosciences” or “Cytek”) (Nasdaq: CTKB), a leading cell analysis solutions company, today reported financial...

CTKB : 4.99 (-4.04%)
Cytek® Biosciences Deepens Commitment to Expanding Access to Flow Cytometry

FREMONT, Calif., Oct. 29, 2025 (GLOBE NEWSWIRE) -- Amid the reduction of various government grant programs and global economic challenges that have tightened research funding, Cytek Biosciences, Inc....

CTKB : 4.99 (-4.04%)
Cytek Biosciences to Report Third Quarter 2025 Financial Results on November 5, 2025

FREMONT, Calif., Oct. 22, 2025 (GLOBE NEWSWIRE) -- Cytek Biosciences, Inc. (“Cytek Biosciences” or “Cytek”) (Nasdaq: CTKB), today announced it will report financial results for the third quarter...

CTKB : 4.99 (-4.04%)
Cytek® Biosciences Expands European Presence with New Facility in Amsterdam to Better Serve Customers and Drive Growth

FREMONT, Calif., Oct. 15, 2025 (GLOBE NEWSWIRE) -- In a move that strengthens its European operations and enhances service for its customers, spectral flow cytometry leader Cytek Biosciences, Inc. ...

CTKB : 4.99 (-4.04%)
Cytek Biosciences Brings Full Spectrum Cell Analysis to Leading Clinical Global Conferences ICCS and ESCCA

FREMONT, Calif., Sept. 10, 2025 (GLOBE NEWSWIRE) -- With cancer research and diagnostics driving the need for deeper, faster cellular insights, spectral flow cytometry leader Cytek Biosciences, Inc....

CTKB : 4.99 (-4.04%)
Cytek Biosciences to Participate in Upcoming Investor Conferences

FREMONT, Calif., Aug. 12, 2025 (GLOBE NEWSWIRE) -- Cytek Biosciences, Inc. (Nasdaq: CTKB), a leading cell analysis solutions company, today announced the company will be participating in the following...

CTKB : 4.99 (-4.04%)
Cytek Biosciences Reports Second Quarter 2025 Financial Results

FREMONT, Calif., Aug. 06, 2025 (GLOBE NEWSWIRE) -- Cytek ®  Biosciences, Inc. (“Cytek Biosciences” or “Cytek”) (Nasdaq: CTKB), a leading cell analysis solutions company, today reported financial...

CTKB : 4.99 (-4.04%)

Business Summary

Cytek Biosciences Inc provides cell analysis solutions. The company developed high-resolution, high-content and high-sensitivity cell analysis technology called Full Spectrum Profiling. Cytek Biosciences Inc is based in FREMONT, Calif.

See More

Key Turning Points

3rd Resistance Point 5.45
2nd Resistance Point 5.33
1st Resistance Point 5.16
Last Price 4.99
1st Support Level 4.87
2nd Support Level 4.75
3rd Support Level 4.58

See More

52-Week High 7.30
Fibonacci 61.8% 5.42
Last Price 4.99
Fibonacci 50% 4.84
Fibonacci 38.2% 4.25
52-Week Low 2.37

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar